Dr. Sandip Patel discusses findings from a real-world study of biomarker testing in early-stage resected non-small cell lung cancer in the U.S.

MK-3000, a tri-specific antibody, is being tested in the BRUNELLO trial for diabetic macular edema, following positive ...

A key barrier in advancing care for ROS1-positive non-small cell lung cancer (NSCLC) is the rarity of the condition, affecting only about 1.5% to 2% of patients. While this still represents a notable ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

By integrating digital tools like ePRO, we can bridge the gap between patients’ lived experiences and clinical research.

Unified data also improves AI outputs. For example, by drawing up-to-date information from a variety of an organization’s systems, an AI agent can more effectively synthesize information to match ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...

A $3.5 million philanthropic gift is helping Cleveland-based University Hospitals Seidman Cancer Center triple its clinical trial capacity by 2030 — ...

Last week’s top stories explored the push for digital-first clinical data systems, why cybersecurity must be central in CRO qualification, and how AI-driven contracting tools are helping sponsors cut ...

Learn how the lack of integration across platforms creates complexity for sites and why holistic solutions are key to ...

BOSTON--(BUSINESS WIRE)--Adams Clinical, LLC (“Adams”, or the “Company”), a leading Neuroscience-focused clinical trial site network announced today that it has agreed on terms of the intent to ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMXT 1501 in combination with ...